Healthcare Professionals
Our Products
Investor Information
LSE:BGC
- 23 Feb 2012
- 11:46am
Quote 354.94p
Change +4.34
Information for investors and analysts.
What's New?
- BTG to present at the Citi Global Health Care Conference
- BTG plc: Directorate Change Amendment
- BTG Announces Positive Data from First US Phase III Trial of Varisolve®
- BTG plc: Interim Management Statement
- Voraxaze® (glucarpidase) receives US regulatory approval
- Check out new Career Opportunities at BTG
- IMPORTANT: Share Scam Alert for Shareholders

